A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Last Updated:
01/24/2018
Status:
Recruiting
Country:
United States
Eligibility:
Age 18+; diagnosed with moderate to severe alopecia areata
Drug:
ATI-50002
Administration:
Topical
Sponsor: 
Aclaris Therapeutics, Inc.

A clinical research study is currently looking for adults with alopecia areata (bald patches on the scalp) to participate in a study of a topical investigational medication. The purpose of this study is to evaluate the safety and effectiveness of two strengths of a topical investigational medication, ATI-50002, or placebo medication when applied to the bald patches on your scalp.

You may qualify to participate if you:

  • are at least 18 years old;
  • have patchy areas of hair loss on the scalp due to alopecia areata;
  • have been experiencing patchy scalp hair loss for at least 6 months and no more than 7 years;
  • are willing to stop any current prohibited treatments for your scalp hair loss;
  • are willing to attend regular study visits (up to 11 visits, 1-4 weeks apart) involving lab tests, electrocardiograms, questionnaires, and other study procedures for the duration of the study (up to 28 weeks).

For participants, all investigational medication, study-related tests and study-related doctor’s visits will be provided at no cost for the duration of the study. Participation is voluntary, and you may withdraw at any time. Participants may be reimbursed for reasonable travel expenses for study visits.

The following trials sites are in your area and may be contacted for more information about participation in the study.

California Dermatology & Clinical Research Institute
Encinitas, CA
Contact: Gigi Jacobson
Phone: 760-203-3839

Alliance Research Centers
Laguna Hills, CA
Contact: Patrick Hullihen
Phone: 949-680-3490

Dermatology Research Associates
Los Angeles, CA
Contact: Kayla Travers
Phone: 310-337-7171

Stanford Medicine Outpatient Center
Redwood City, CA
Contact: Yana Dutt-Singkh
Phone: 650-498-4880

Colorado Medical Research Center, Inc.
Denver, CO
Contact: Davene Riesmeyer, BSN or Carolyn Schmidt, RN
Phone: 303-744-7000

Center for Dermatology and Dermatologic Surgery
Washington, DC
Contact: Keren Moore
Phone: 202-955-5757

Siperstein Dermatology Group
Boynton Beach, FL
Contact: Stacy Stankiewicz
Phone: 561-364-7774 x 322

University of Miami Hospital
Miami, FL
Contact: Marcela Salgado
Phone: 305-689-3376

Brigham and Women’s Hospital
Boston, MA
Contact: Elizabeth Lowry
Phone: 617-525-8511

Michigan Center for Skin Care Research
Clinton Township, MI
Phone: 586-286-7325
*Reference Patchy Alopecia Study

Grekin Skin Institute
Warren, MI
Contact: Claudia Attala
Phone: 586-759-5525

Minnesota Clinical Study Center
Fridley, MN
Contact: Allie Horita
Phone: 763-571-4200

University of Minnesota Dermatology Department
Minneapolis, MN
Contact: Irmina Wallander
Phone: 612-624-5721

Duke Dermatopharmacology Study Center
Durham, NC
Phone: 919-668-5610
*Reference Patchy Alopecia Study

Wake Forest University Health Sciences
Winston Salem, NC
Contact: Judy Holbrook
Phone: 336-716-8991

Skin Specialists
Omaha, NE
Contact: Ashley Bell
Phone: 402-697-6599

Skin Specialty Dermatology
New York, NY
Contact: Brittany Butler
Phone: 212-223-6599

NW Dermatology and Research Center, LLC
Portland, OR
Contact: Heather Cook, CCRC
Phone: 503-223-1933 Ex 105

Leavitt Medical Associates
Fort Washington, PA
Contact: Donna Keenan
Phone: 215-836-7900 Ex 7

The Skin Wellness Center
Knoxville, TN
Contact: Kim Brefini
Phone: 865-251-9941

Tennessee Clinical Research Center
Nashville, TN
Contact: April Wilson
Phone: 615-383-9660 Ex 175

DermResearch, Inc.
Austin, TX
Phone: 512-349-0500
*Reference Alopecia Study

Tekton Research
Austin, TX
Phone: 512-388-5717
*Ask for a Recruiter

Bellaire Dermatology Associates
Bellaire, TX
Contact: Harmony Saqr
Phone: 832-553-2339

Progressive Clinical Research
San Antonio, TX
Contact: Colleen James
Phone: 210-614-5557